APA
Gaudig M., Ireland S., Musingarimi P., Jackson C., Tweats E., Eriksson J. A. & Landfeldt E. (20160610). What Relapsed/Refractory Cll/Mcl Treatment Outcomes Do German Patients And Physicians Find Most Important? Results from Qualitative Interviews. : Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
Chicago
Gaudig M, Ireland S, Musingarimi P, Jackson C, Tweats E, Eriksson J A and Landfeldt E. 20160610. What Relapsed/Refractory Cll/Mcl Treatment Outcomes Do German Patients And Physicians Find Most Important? Results from Qualitative Interviews. : Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
Harvard
Gaudig M., Ireland S., Musingarimi P., Jackson C., Tweats E., Eriksson J. A. and Landfeldt E. (20160610). What Relapsed/Refractory Cll/Mcl Treatment Outcomes Do German Patients And Physicians Find Most Important? Results from Qualitative Interviews. : Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
MLA
Gaudig M, Ireland S, Musingarimi P, Jackson C, Tweats E, Eriksson J A and Landfeldt E. What Relapsed/Refractory Cll/Mcl Treatment Outcomes Do German Patients And Physicians Find Most Important? Results from Qualitative Interviews. : Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 20160610.